SCHEMBL19445600

SCHEMBL19445600

COc1ccc(NC(=O)[C@@H](CCCNC(=N)N)NC(=O)c2cc(NC(=O)CNC(=O)c3cc(NC(=O)CNC(=O)c4cc(NC(=O)CNC(=O)CCCCNC(=N)N)ccc4OC)ccc3OC)ccc2OC)cc1C(N)=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.38
▸ NPY5R Q15761 6/20 0.38
▸ NPY4R P50391 6/20 0.38
▸ NPY1R P25929 5/20 0.38
▸ NPY2R P49146 3/20 0.38
▸ HDAC1 Q13547 3/20 0.37
▸ HDAC3 O15379 2/20 0.37
▸ EGFR P00533 1/20 0.37
▸ HDAC4 P56524 1/20 0.37
▸ HDAC7 Q8WUI4 1/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ HDAC10 Q969S8 1/20 0.37
▸ HDAC11 Q96DB2 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37
▸ HDAC9 Q9UKV0 1/20 0.37
▸ HDAC5 Q9UQL6 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MMP2 P08253 2/20 0.36
▸ TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10263117 0.94 HDAC1 (0.42) NPC1NPY5RNPY4RNPY1RNPY2R
SCHEMBL10260131 0.93 NPY4R (0.43) NPY5RNPY4RNPY1RNPY2RHDAC1
SCHEMBL19445627 0.92 NPC1 (0.39) NPC1NPY5RNPY4RNPY1RNPY2R
SCHEMBL19445529 0.92 NPY4R (0.42) NPY5RNPY4RNPY1RNPY2RHDAC1
SCHEMBL19445747 0.92 NPY4R (0.37) NPC1NPY5RNPY4RNPY1RNPY2R
SCHEMBL10262456 0.91 NPY4R (0.45) NPY5RNPY4RNPY1RNPY2RHDAC1
SCHEMBL19485986 0.90 NPC1 (0.45) NPC1HDAC1HDAC3EGFRHDAC4
SCHEMBL12515239 0.90 NPY4R (0.37) NPC1NPY5RNPY4RNPY1RNPY2R
SCHEMBL19445632 0.89 NPY4R (0.40) NPC1NPY5RNPY4RNPY1RNPY2R
SCHEMBL10262202 0.89 NPY4R (0.43) NPY5RNPY4RNPY1RNPY2RHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2709619-B1 COMPOUNDS FOR USE IN TREATMENT OF MUCOSITIS CELLCEUTIX CORP (US) 2017-10-11 — — EP disclosed
Send feedback